Clinical trial
Infant Aphakia Treatment Study (IATS)
NCT00212134 · Stanford University, Other · Completed
Key facts
| NCT number | NCT00212134 |
|---|---|
| Title | Infant Aphakia Treatment Study (IATS) |
| Official title | Infant Aphakia Treatment Study (IATS) |
| Acronym | IATS |
| Lead sponsor | Stanford University, Other |
| Collaborators | National Eye Institute (NEI) NIH Alcon Research Industry Bausch & Lomb Incorporated BSN-JOBST Inc. Eye Care and Cure |
| Status | Completed |
| Study type | Interventional |
| Conditions | Congenital Cataract |
| Intervention type | Device |
| Interventions | Contact lens correction of aphakia, Intraocular lens implantation |
| Enrollment | 114 |
| Start date | Dec 1, 2004 |
| Primary completion | Aug 31, 2020 |
| Completion | Aug 31, 2020 |
| First posted | Sep 21, 2005 |
| Last update posted | Jul 24, 2024 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: